Releases

Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.  Read More

Vanderbilt University Medical Center (VUMC) researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease. Read More

Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read More

Vanderbilt emeritus professor of economics John Vrooman, who had a passion for all things sports and taught one of the most popular classes at Vanderbilt focusing on sports economics, passed away on July 5. Before he passed, Vrooman asked that he not have an official obituary, but fellow economics professor Robert Driskill wrote this remembrance of Vrooman, who had a teaching career that spanned almost five decades. Read More

People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered. Read More

Vanderbilt University Medical Center is evaluating razuprotafib, a drug used to treat glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19. Read More

The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.  Read More

Vanderbilt University Medical Center investigators have used high-throughput robotic technology to rapidly study and classify variations in a gene linked to heart rhythm disorders and cardiac conditions. Read More

Vanderbilt University Medical Center scientists have identified a C. diff protein system that senses and captures heme (part of hemoglobin) to build a protective shield that fends off threats from our immune system and antibiotics. Read More

After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio. Read More

The Division of TennCare will partner with VUMC as part of the MOM program focusing on 26 rural and urban counties to improve the outcomes for women with opioid use disorder and their infants. Read More

If the Tennessee Valley Authority goes private, utility customers could benefit if risks and incentives are better aligned than under the current approach, according to a Vanderbilt law professor. The prospect of selling off the public utility has been raised by the Obama administration in a call for a strategic review. Read More